Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients

Vaccination against SARS-CoV-2 to prevent COVID-19 is highly recommended for immunocompromised patients with autoimmune rheumatic and musculoskeletal diseases (aiRMDs). Little is known about the effect of booster vaccination or infection followed by previously completed two-dose vaccination in aiRMD...

Descripción completa

Detalles Bibliográficos
Autores principales: Honfi, Dániel, Gémes, Nikolett, Szabó, Enikő, Neuperger, Patrícia, Balog, József Á., Nagy, Lajos I., Toldi, Gergely, Puskás, László G., Szebeni, Gábor J., Balog, Attila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569441/
https://www.ncbi.nlm.nih.gov/pubmed/36232710
http://dx.doi.org/10.3390/ijms231911411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569441/
https://www.ncbi.nlm.nih.gov/pubmed/36232710
http://dx.doi.org/10.3390/ijms231911411

Ejemplares similares